OXIFLOW Next-Generation Flow Diverter

About Oxford Endovascular

Oxford Endovascular is a private, clinical-stage medical device company targeting the rapidly growing neurovascular intervention market, estimated at over $1 billion. The company is developing a patented, origami-engineered flow-diverter for the treatment of brain aneurysms, a condition affecting 1 in 50 people. With strong academic roots and over $10 million raised, including significant non-dilutive EU grant funding, the company is advancing toward first-in-human clinical studies. Its leadership combines deep clinical neuroradiology expertise with engineering innovation and seasoned medtech entrepreneurship.

Therapeutic Areas